agilon health (NYSE:AGL) Price Target Raised to $3.00

agilon health (NYSE:AGL) had its price target hoisted by Stifel Nicolaus from $2.00 to $3.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a hold rating on the stock.

Other analysts have also issued reports about the stock. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th. TD Cowen lowered their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Finally, Sanford C. Bernstein lifted their price objective on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $3.95.

agilon health Price Performance

agilon health stock opened at $3.12 on Wednesday. The firm has a market capitalization of $1.29 billion, a PE ratio of -3.32 and a beta of 0.66. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The firm’s 50-day simple moving average is $2.96 and its 200 day simple moving average is $3.03. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insiders Place Their Bets

In other news, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karen Mcloughlin purchased 25,000 shares of the company’s stock in a transaction on Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 77,500 shares of company stock valued at $169,600 over the last quarter. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of institutional investors have recently modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in agilon health by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock valued at $1,516,000 after buying an additional 157,610 shares in the last quarter. Two Sigma Advisers LP raised its stake in shares of agilon health by 4,393.5% in the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock valued at $914,000 after acquiring an additional 470,100 shares during the period. Two Sigma Investments LP lifted its holdings in shares of agilon health by 73.7% during the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock valued at $1,630,000 after acquiring an additional 363,855 shares in the last quarter. State of Wyoming boosted its position in agilon health by 89.3% during the 4th quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after purchasing an additional 57,802 shares during the period. Finally, Point72 Asset Management L.P. acquired a new stake in agilon health in the 4th quarter valued at $768,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.